Literature DB >> 15217537

The global smoking epidemic: a history and status report.

Robert N Proctor1.   

Abstract

The World Health Organization estimates that tobacco causes approximately 5 million deaths annually worldwide, a number expected to double by 2025. Cigarette consumption grew from only a few billion per year in 1900 to present values of approximately 5.5 trillion worldwide. Historical causes for the rise of smoking include the invention of flue curing, safety matches, and cigarette rolling machines, but also the distribution of cigarettes to soldiers during World War I, mass marketing, the failure of governments to limit consumption, and the duplicitous denial of hazards by manufacturers. Cancers of the lip, throat, and tongue were linked to tobacco as early as the 18th century, but a lung cancer hazard from smoking was not suspected until the first decade of the 20th century. Epidemiologic evidence began to emerge in the 1920s, and by the 1950s, the causal link with cigarette smoking was well established. Epidemiologic studies, animal experiments, and studies demonstrating pathologic changes in lung tissues at autopsy were 3 pivotal sources of evidence. However, the tobacco industry refused to concede the reality of tobacco hazards until the late 1990s. Instead, the industry sought to target physicians and others with its message of "no proof," using subtle techniques of deception, including the funding of spurious research, duplicitous press releases, propaganda efforts directed at physicians, and the employment of historians to construct exculpatory narratives. The World Health Organization's Framework Convention on Tobacco Control promises to standardize global tobacco control measures, including policies to limit smuggling. Effective means of reducing tobacco use include counter-advertising, increased taxation, smoke-free workplace legislation, and litigation against the industry.

Entities:  

Mesh:

Year:  2004        PMID: 15217537     DOI: 10.3816/CLC.2004.n.016

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  27 in total

1.  Differential in vivo effects of whole cigarette smoke exposure versus cigarette smoke extract on mouse ciliated tracheal epithelium.

Authors:  Margaret K Elliott; Joseph H Sisson; William W West; Todd A Wyatt
Journal:  Exp Lung Res       Date:  2006 Mar-Apr       Impact factor: 2.459

Review 2.  Cigarette smoking and inflammation: cellular and molecular mechanisms.

Authors:  J Lee; V Taneja; R Vassallo
Journal:  J Dent Res       Date:  2011-08-29       Impact factor: 6.116

3.  Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors.

Authors:  Abhiram Pushparaj; Clement Hamani; Wilson Yu; Damian S Shin; Bin Kang; José N Nobrega; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2012-11-15       Impact factor: 7.853

4.  The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study.

Authors:  Alan G Nyitray; Fen Peng; Rena S Day; Roberto J Carvalho Da Silva; Maria Luiza Baggio; Jorge Salmerón; Manuel Quiterio; Martha Abrahamsen; Eduardo Lazcano-Ponce; Luisa L Villa; Anna R Giuliano
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

5.  Not simply the lesser of two evils.

Authors:  S Vamsee Raju; Steven M Rowe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-20       Impact factor: 5.464

Review 6.  The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.

Authors:  Josiah Ochieng; Gladys N Nangami; Olugbemiga Ogunkua; Isabelle R Miousse; Igor Koturbash; Valerie Odero-Marah; Lisa J McCawley; Pratima Nangia-Makker; Nuzhat Ahmed; Yunus Luqmani; Zhenbang Chen; Silvana Papagerakis; Gregory T Wolf; Chenfang Dong; Binhua P Zhou; Dustin G Brown; Anna Maria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Rabeah Al-Temaimi; Fahd Al-Mulla; William H Bisson; Sakina E Eltom
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 7.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

8.  Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.

Authors:  Neil E Paterson; Styliani Vlachou; Sebastien Guery; Klemens Kaupmann; Wolfgang Froestl; Athina Markou
Journal:  J Pharmacol Exp Ther       Date:  2008-04-29       Impact factor: 4.030

9.  Toxicogenomic analysis of mainstream tobacco smoke-exposed mice reveals repression of plasminogen activator inhibitor-1 gene in heart.

Authors:  Sabina Halappanavar; Martin R Stampfli; Lynn Berndt-Weis; Andrew Williams; George R Douglas; Carole L Yauk
Journal:  Inhal Toxicol       Date:  2009-01       Impact factor: 2.724

10.  Induction of the interleukin 6/ signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke.

Authors:  Sabina Halappanavar; Marsha Russell; Martin R Stampfli; Andrew Williams; Carole L Yauk
Journal:  BMC Med Genomics       Date:  2009-08-21       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.